Table 3.
Characteristics of the sample stratified on of the CCI ≤ 12.2 and > 12.2.
| Comprehensive Complication Index (CCI) | |||||
|---|---|---|---|---|---|
| Total n = 105 |
CCI ≤ 12.2 n = 68 (64.76%) |
CCI > 12.2 n = 37 (35.24%) |
p-Value | ||
| Age, median (IQR) | 69 (58–78) | 73 (58–78) | 67 (53–76) | 0.354 * | |
| Sex, n (%) | 0.002 ** | ||||
| Male | 61 (58.10) | 47 (69.12) | 14 (37.84) | ||
| Female | 44 (41.90) | 21 (30.88) | 23 (62.16) | ||
| BMI, median (IQR) | 24.47 (22.20–26.65) | 24.51 (22.33–26.72) | 24.14 (21.81–26.31) | 0.620 * | |
| ASA Score, n (%) | 0.817 ** | ||||
| I/II | 64 (60.95) | 42 (61.76) | 22 (59.46) | ||
| III | 41 (39.05) | 26 (38.24) | 15 (40.54) | ||
| CI, n (%) | 0.473 *** | ||||
| 0 | 68 (64.76) | 47 (69.12) | 21 (56.76) | ||
| 1 | 28 (26.67) | 16 (23.53) | 12 (32.43) | ||
| ≥2 | 9 (8.57) | 5 (7.35) | 4 (10.81) | ||
| Previous cancer history, n (%) | 0.349 ** | ||||
| No | 82 (78.10) | 55 (80.88) | 27 (72.97) | ||
| Yes | 23 (21.90) | 13 (19.12) | 10 (27.03) | ||
| Days between HP and HR, median (IQR) | 152 (62–250) | 119 (60–201) | 196 (92–282) | 0.005 * | |
| Operating time (min), median (IQR) | 185 (135–235) | 165 (125–223) | 200 (170–250) | 0.005 * | |
| Hospital stay (days), median (IQR) | 8 (8–10) | 8 (7–10) | 10 (8–13) | 0.002 * | |
* Wilcoxon rank-sum (Mann–Whitney) test, ** χ2 test, *** Fisher’s exact test, IQR: interquartile range, BMI: body mass index, CI: Charlson Index, ASA: American Society of Anesthesiologists, CCI: Comprehensive Complication Index, HP: Hartmann’s Procedure, HR: Hartmann’s Reversal.